Target Concerns: Dullness, dark spots, loss of firmness, fine lines, dehydration, uneven tone, signs of aging, lack of radiance, oxidative stress
Now that the MDL has been created, the litigation will move into an organized pretrial phase
It is part of my new textbook - HOMOCYSTEINE THE 2025 COMPREHENSIVE DIAGNOSIS & TREATMENT PROTOCOL - I'll be publishing chapters on here moving forward
A systematic review and meta-analysis of 12 randomized controlled trials (RCTs) involving 11 459 overweight or obese adults without diabetes demonstrated that GLP-1 receptor agonists significantly reduced body weight, alongside notable improvements in glycemic control, lipid levels, and blood pressure
Voros C, Chatzinikolaou F, Papapanagiotou I, Polykalas S, Mavrogianni D, Koulakmanidis AM, Athanasiou D, Kanaka V, Bananis K, Athanasiou D, Athanasiou A, Papadimas G, Tsimpoukelis C, Vaitsis D, Karpouzos A, Daskalaki MA, Kanakas N, Theodora M, Thomakos N, Antsaklis P, Loutradis D, Daskalakis G
Your information will be kept strictly confidential